EU agency recommends against Zentiva's Coxtral gel
LONDON, June 2 (Reuters) - The European Medicines Agency has reiterated its decision against recommending approval of Zentiva's ZNTVsp.PR Coxtral gel for relief of pain associated with sprains and acute traumatic tendinitis.
The London-based watchdog said on Monday that the decision confirms its February opinion recommending against refusal to grant marketing approval for the drug in Europe. (Reporting by Michael Kahn)
© Thomson Reuters 2009 All rights reserved
Dubai Debt Fears
Banks outside the Gulf played down their exposure to Dubai debt, after fears the emirate could default and even derail world economic recovery prompted a sell-off in global markets. Full Article | Slideshow
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India. Full Coverage





India
US
UK







